8:55am ET
Investing
4 Top Jefferies Value Stocks to Buy This Week
Each week we cover the new value calls from the analysts at Jefferies, and more and more, some of the calls may look surprising.
Companies
/Healthcare
Abbvie Inc
$262.90
▼ $2.89 (−1.09%) today
Markets closed · 8:31pm ET
ABBV Coverage
Page 37
9:40am ET
Health and Healthcare
8 BioPharma Movers That Cannot Be Ignored
These biotech stocks 24/7 Wall St. has picked stood out from the rest with at least 25% gains over the course of the past week.
9:10am ET
Investing
Top Analyst Upgrades and Downgrades: AbbVie, Alphabet, Amazon, Apple, Microsoft, Pandora, McDonald’s, Many More
Friday's top analyst upgrades, downgrades and initiations include AbbVie, Alphabet, Amazon.com, American Electric Power, Apple, Microsoft, Pandora Media and McDonald's.
4:31pm ET
Health and Healthcare
How FDA Warning Could Spell Disaster for AbbVie and Opportunity for Gilead
ThinkstockThe U.S. Food and Drug Administration (FDA) issued a warning that hepatitis C treatments, Viekira Pak and Technivie, can cause serious liver injury mostly in patients with underlying advanced liver disease. The…
10:15am ET
Investing
Jefferies Franchise Pick Stocks to Buy That Also Pay Big Dividends
These Jefferies Franchise picks with solid dividends are perfect for long-term accounts that like to employ a buy-and-hold strategy.
9:25am ET
Health and Healthcare
Short Sellers Become More Selective on Major Pharma
The September 30 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks, short interest was mixed.
8:20am ET
Investing
Credit Suisse Adds Blue Chip Dividend Stocks to Prestigious Top Picks List
Credit Suisse is adding some top conservative dividend-paying stocks to its Top Picks list, and that is right in line with what other top Wall Street firms are doing.
8:40am ET
Health and Healthcare
Short Sellers Boost Positions in Major Pharma
The September 15 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks, short interest has increased.
8:25am ET
Health and Healthcare
Short Sellers Become More Selective in Major Pharma
The short interest data have been released for the August 31 settlement date, and for the selected pharmaceutical stocks, short interest is mixed.
4:18pm ET
Health and Healthcare
AbbVie Posts Another Win for Humira
ThinkstockAbbVie Inc. (NYSE: ABBV) has continued to push forward over the past year and shares are actually up 7.3% in the past 52-weeks despite the markets pulling back in August. Late Thursday,…
Chris Lange 8:05am ET
Health and Healthcare
Short Sellers Have Mixed Feelings on Major Pharma
The August 14 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks, short interest is mixed.
8:22am ET
Health and Healthcare
4 Top Pharma Stocks That Should Outperform Out To 2016
ThinkstockWith a very nervous market, and the end of summer doldrums upon us, it may be time to look for ideas that will make sense when the market heats back up in…
9:45am ET
Health and Healthcare
Short Sellers Back Off Big Pharma
The short interest data have been released for the July 31 settlement date, and for most of the selected pharmaceutical stocks, short interest decreased.
3:19pm ET
Health and Healthcare
Why AbbVie Should Be Worth 25% More
Independent research firm Argus has maintained its Buy rating and its $85.00 price target on AbbVie.
8:21am ET
Health and Healthcare
Short Sellers Run For Cover From Major Pharma
ThinkstockThe short interest data have been released for the July 15 settlement date. Pharmaceutical companies are usually involved in a lengthy process in getting their drug candidates to market through clinical trials.…